Source: JF19
According to a report by The Free Press, the state of Florida may receive lower-than-expected revenue from the tobacco industry due to a decrease in the number of smokers and a decrease in the amount of tobacco consumed by remaining smokers.
In 1998, the largest tobacco company in the United States settled a lawsuit brought by state attorneys general over the costs of treating sick smokers. The tobacco industry agreed to pay billions of dollars over the course of more than 20 years, with the payment amount based on the quantity of cigarettes sold.
According to a report released on August 5th, economists are predicting that Florida will receive $412.1 million in settlement funds by the end of the year, which is lower than the previously estimated $413.8 million.
The report indicates that cigarette sales are predicted to decline by 2.5% annually over the next decade.
Previously, the projected decline was expected to be between 1.44% to 1.75%. The report also stated that payments made by tobacco manufacturers were $1.7 million less than expected for the recently completed 2021-2022 fiscal year.
During the state revenue estimation conference, economists also revised their projections for future payments over the next few years.
It was previously projected that the revenue for the 2023-2024 fiscal year would be $442.5 million, but now it is estimated that the state will obtain $417.9 million through a settlement during this period.
Statement:
This article is compiled from third-party information and is intended for industry professionals for communication and learning purposes.
This article does not represent the views of 2FIRSTS. 2FIRSTS is also unable to confirm the authenticity and accuracy of the article's contents. The translation of this article is only intended for industry exchange and research purposes.
Due to limitations in translation ability, translated articles may not fully express the intended meaning of the original text. Please refer to the original text for accuracy.
2FIRSTS is fully aligned with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
